New Drug Overcome Prostate Cancer

New Drug Overcome Prostate Cancer - Hopes for prostate cancer patients seem to be getting a big heal after scientists succeeded in developing a new drug called abiraterone. Scientists welcomed the enthusiastic presence of abiraterone and judge it as the most significant advances in the field of cancer treatment during the last 70 years.

According to experts from the Institute of Cancer Research, cancer research center based in the UK who developed abiraterone, this drug should be proud of because it claimed to be able to treat up to 80 percent of patients with this deadly disease. This drug works effectively by blocking the hormones that trigger the onset of cancer

The Institute of Cancer Research hopes a simple pill form abiraterone will be available in two or three years. Clinical trials involving about 1,200 patients worldwide are currently still being implemented and will be followed by a number of advanced research at the end of this year.


Prostate cancer itself is a type of cancer most commonly found among men. Life expectancy following chemotherapy is usually not more than 18 months. Experts assume that prostate cancer is also influenced by sex hormones such as testosterone produced in the testes. This type of treatment used to do now is to stop the testes produce testosterone.

However, experts have managed to find the fact that cancer can also get a sex hormone from many sources, including from the hormones produced by the tumor itself. This is where the role abiraterone mennghambat and blocking the production of hormones throughout the body.

Research is also published in the Journal of Clinical Oncology, is a result of monitoring prostate cancer patients that are aggressive and already in an advanced stage. Patients given the drug abiraterone and research data collected from around the world.

Research results indicate a significant shrinkage of tumor size as well as any decrease in levels of a protein is important that the resulting cancer called prostate specific antigen in patients mayotitas.

Most patients reported to show significant progress and improvements in the quality of their lives. Some of them can stop the consumption of morphine for pain caused by the spread of disease in their bones.